Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects
Clinical trial NCT00748150 · COMPLETED
Trial details
- NCT number
- NCT00748150
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-08-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.